Reference - Detail
| RRC ID | 75574 |
|---|---|
| Author | Hosomi K, Saito M, Park J, Murakami H, Shibata N, Ando M, Nagatake T, Konishi K, Ohno H, Tanisawa K, Mohsen A, Chen YA, Kawashima H, Natsume-Kitatani Y, Oka Y, Shimizu H, Furuta M, Tojima Y, Sawane K, Saika A, Kondo S, Yonejima Y, Takeyama H, Matsutani A, Mizuguchi K, Miyachi M, Kunisawa J. |
| Title | Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota. |
| Journal | Nat Commun |
| Volume | 13(1) |
| Pages | 4477 |
| Published | 2022-8-18 |
| DOI | 10.1038/s41467-022-32015-7 |
| PII | 10.1038/s41467-022-32015-7 |
| PMID | 35982037 |
| PMC | PMC9388534 |
| MeSH | Acetylcholine Administration, Oral Adult Amylopectin Animals Carbohydrate Metabolism* Clostridiales* / metabolism Cross-Sectional Studies Diabetes Mellitus, Type 2* / microbiology Diabetes Mellitus, Type 2* / therapy Diet, High-Fat / adverse effects Gastrointestinal Microbiome* / physiology Humans Japan Mice Mice, Inbred C57BL Obesity* / microbiology Obesity* / therapy Ornithine Symbiosis |
| Resource | |
| General Microbes | JCM 17041 JCM 5826 JCM 13464 JCM 31915 JCM 31056 |